Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

503 indexed citations
published 2004

Countries where authors are citing Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

Specialization
Citations

This map shows the geographic impact of Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways more than expected).

Fields of papers citing Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways.

About Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

This paper, published in 2004, received 503 indexed citations . Written by Harry Björkbacka, Vidya Kunjathoor, Kathryn J. Moore, Melinda A. Lee, Terry K. Means, Kristen A. Halmen, Andrew D. Luster, Douglas T. Golenbock and Mason W. Freeman covering the research area of Immunology. It is primarily cited by scholars working on Immunology (370 citations), Epidemiology (149 citations) and Molecular Biology (140 citations). Published in Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm1008.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026